Sotirimod

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSotirimod
Drug Alias NameSotirimodum索替莫德S-30594R-850IRM-6
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunostimulantsToll like receptor 7 agonists
TargetsToll like receptor 7
Therapy Area/IndicationsKeratosis, Actinic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator Companies3m Healthcare Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMeda Ab3m Healthcare Ltd
Active IndicationsN/A
Inactive IndicationsKeratosis, Actinic

Other Information

ATC CodeN/A
Related LinksKEGG